{'_data': [['Unknown',
            [['GI',
              u'Episodes of dehydration (associated with diarrhoea and/or vomiting) Constipation relative to irinotecan hydrochloride and/or loperamide Uncommon Pseudo-membranous colitis (one has been documented bacteriological: Clostridium difficile) Renal insufficiency, hypotension or cardio-circulatory failure as a consequence of dehydration associated with diarrhoea and/or vomiting Intestinal obstruction, ileus, or gastrointestinal haemorrhage Rare Colitis, including typhlitis, ischemic and ulcerative colitis, Intestinal perforation Other mild effects include anorexia, abdominal pain and mucositis Symptomatic or asymptomatic pancreatitis Blood and lymphatic system disorders: Very common Neutropenia (reversible and not cumulative) Anaemia Thrombocytopenia in case of combination therapy Common Febrile neutropenia Infectious episodes (some cases associated with severe neutropenia and resulted in death in 2 cases) Thrombocytopenia in case of monotherapy Very rare One case of peripheral thrombocytopenia with antiplatelet antibodies has been reported. Skin and subcutaneous tissue disorders Very common Alopecia (reversible) Uncommon Mild cutaneous reactions General disorders and administration site reactions: Very common Fever in the absence of infection and without concomitant severe neutropenia Common Severe transient acute cholinergic syndrome (The main symptoms were defined as early diarrhoea and various other symptoms such as abdominal pain, conjunctivitis, rhinitis, hypotension, vasodilatation, sweating, chills, malaise, dizziness, visual disturbances, myosis, lacrimation and increased salivation) Asthenia Uncommon Infusion site reactions Investigations: Very common In combination therapy transient serum levels (grade 1 and 2) of serum transaminases, alkaline phosphatase or bilirubin were observed in the absence of progressive liver metastasis. Common In monotherapy, transient and mild to moderate increases in serum levels of either transaminases, alkaline phosphatase or bilirubin were observed in the absence of progressive liver metastasis. Transient and mild to moderate increases of serum levels of creatinine Rare Hypokalemia and hyponatremia Very rare Increases of amylase and/or lipase Respiratory, thoracic and mediastinal disorders: Uncommon Interstitial pulmonary disease presenting as pulmonary infiltrates Early effects such as dyspnoea Organ system Frequency Side effects Immune system disorders: Uncommon Mild allergy reactions Rare Anaphylactic/ Anaphylactoid reactions Infections and Infestations: Uncommon Renal insufficiency, hypotension or cardio-circulatory failure have been observed in patients who experienced sepsis. Cardiac disorders: Rare Hypertension during or following the infusion. Musculoskeletal and connective tissue disorders: Rare Early effects such as muscular contraction or cramps and paraesthesia Nervous system disorders: Very rare Transient speech disorders']]]],
 '_pages': [11, 14],
 u'_rank': 1,
 u'_type': u'LSFU'}